Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 14Uterine Cervical Neoplasms 10Fallopian Tube Neoplasms 9Carcinoma, Ovarian Epithelial 7Peritoneal Neoplasms 4Neoplasm, Residual 2Stomach Neoplasms 1Stage III and IV Ovarian Cancer 1Sarcoma 1Recurrence 1Postoperative Complications 1Neoplasms 1Locally Advanced Cervical Cancer 1Intermittent Fasting 1Endometrial Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Carcinoma 1Advanced Ovarian Cancer 1

Interventions

Cisplatin 7Radiotherapy 3Paclitaxel 3Carboplatin 3Brachytherapy 2zimberelimab 1piperine 1pembrolizumab 1durvalumab 1camrelizumab 1atezolizumab 1Sodium Chloride 1Neoadjuvant Therapy 1Gemcitabine 1Drug Therapy 1Curcumin 1Chemoradiotherapy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Cancer × Neoadjuvant Therapy × Gynecologic × Clear all
NCT06916117 2025-04-08

Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC

RenJi Hospital

Phase 2 Not yet recruiting
30 enrolled
Gynecologic

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡